Abstract
Liver failure is a catastrophic illness associated with the death of many patients who are waiting for transplantation. Currently there are no effective treatments for this disease, therefore scientists have paid their attention to the field of stem cells, which has helped to understand the pathogenesis of liver disease, expanded the drug discovery processes, and could potentially be used as an alternative therapy. Recent reports demonstrating the production of liver like cells derived from bone marrow and embryonic stem cells, have established a better understanding of the soluble factors and biochemical compounds that are essential in liver development. Although considerable progress has been made in differentiating stem cells into liver cells, current protocols have not yet produced cells with the phenotype of a complete mature hepatocyte. Therefore, the proper criteria for defining what constitutes a functional human stem cell-derived hepatocyte are required. This review describes the current challenges and future opportunities in Embryonic Stem cell differentiation to liver cells, and the appropriate characteristics needed for their future clinical use in the treatment of liver disease.
Keywords: Stem cell-derived hepatocytes, Embryonic stem cells, liver-based therapies
Current Stem Cell Research & Therapy
Title: Stem Cell Research and Therapy for Liver Disease
Volume: 4 Issue: 2
Author(s): Nalu Navarro-Alvarez, Alejandro Soto-Gutierrez and Naoya Kobayashi
Affiliation:
Keywords: Stem cell-derived hepatocytes, Embryonic stem cells, liver-based therapies
Abstract: Liver failure is a catastrophic illness associated with the death of many patients who are waiting for transplantation. Currently there are no effective treatments for this disease, therefore scientists have paid their attention to the field of stem cells, which has helped to understand the pathogenesis of liver disease, expanded the drug discovery processes, and could potentially be used as an alternative therapy. Recent reports demonstrating the production of liver like cells derived from bone marrow and embryonic stem cells, have established a better understanding of the soluble factors and biochemical compounds that are essential in liver development. Although considerable progress has been made in differentiating stem cells into liver cells, current protocols have not yet produced cells with the phenotype of a complete mature hepatocyte. Therefore, the proper criteria for defining what constitutes a functional human stem cell-derived hepatocyte are required. This review describes the current challenges and future opportunities in Embryonic Stem cell differentiation to liver cells, and the appropriate characteristics needed for their future clinical use in the treatment of liver disease.
Export Options
About this article
Cite this article as:
Navarro-Alvarez Nalu, Soto-Gutierrez Alejandro and Kobayashi Naoya, Stem Cell Research and Therapy for Liver Disease, Current Stem Cell Research & Therapy 2009; 4 (2) . https://dx.doi.org/10.2174/157488809788167418
DOI https://dx.doi.org/10.2174/157488809788167418 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Tea Polyphenols and their Polymers on MAPK Signaling Pathways in Cancer Research
Mini-Reviews in Medicinal Chemistry Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Mechanisms of Cytotoxicity of Anticancer Titanocenes
Anti-Cancer Agents in Medicinal Chemistry Machine Learning for Mass Spectrometry Data Analysis in Proteomics
Current Proteomics Recent Developments in the Pharmacological Properties of 4'-Geranyloxyferulic Acid, a Colon Cancer Chemopreventive Agent of Natural Origin
Current Drug Targets Intestinal Targeting of Drugs: Rational Design Approaches and Challenges
Current Topics in Medicinal Chemistry Lectin Techniques for Glycoproteomics
Current Proteomics Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery Targeting RSK: An Overview of Small Molecule Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Meet Our Editorial Board Member:
Current Drug Targets Behavior of EDTMP (Ethylene-diaminetetramethylene-phosphonate)- Nanoparticles in Blood: Considerations on the Site of Injection
Current Nanoscience Targeting Bcl-2 Family of Proteins: An Important Strategy in Cancer Therapeutics
Current Chemical Biology PPARγ: Potential Therapeutic Target for Ailments Beyond Diabetes and its Natural Agonism
Current Drug Targets MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Probable Mechanisms Involved in Immunotoxin Mediated Capillary Leak Syndrome (CLS) and Recently Developed Countering Strategies
Current Molecular Medicine Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required
Current Cancer Drug Targets Are Selenoproteins Important for the Cancer Protective Effects of Selenium?
Current Nutrition & Food Science Melatonin, Autophagy and Intestinal Bowel Disease
Current Pharmaceutical Design A Comparative Study of the Cytotoxic and Pro-apoptotic Properties of Nepeta binaloudensis
Letters in Drug Design & Discovery PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery